News
TORONTO, Sept. 28, 2017 /PRNewswire/ -- Impopharma Inc. ("Impopharma") today announced that it has entered into an asset purchase, license, and commercialization agreement with Breckenridge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback